Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Equity (2018 - 2025)

Dna X's Return on Equity history spans 8 years, with the latest figure at 1.92% for Q4 2025.

  • Quarterly results put Return on Equity at 1.92% for Q4 2025, up 257.0% from a year ago — trailing twelve months through Dec 2025 was 1.92% (up 257.0% YoY), and the annual figure for FY2025 was 1.86%, up 555.0%.
  • Return on Equity for Q4 2025 was 1.92% at Dna X, down from 2.81% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 2.81% in Q3 2025 to a low of 3.78% in Q2 2022.
  • The 5-year median for Return on Equity is 0.59% (2024), against an average of 0.71%.
  • The sharpest move saw Return on Equity crashed -194bps in 2022, then soared 369bps in 2023.
  • Year by year, Return on Equity stood at 2.47% in 2021, then soared by 72bps to 0.69% in 2022, then soared by 103bps to 0.02% in 2023, then crashed by -3766bps to 0.65% in 2024, then skyrocketed by 397bps to 1.92% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 1.92%, 2.81%, and 0.51% for Q4 2025, Q3 2025, and Q2 2025 respectively.